Remove Biosimilars Remove Labelling Remove Process Improvement
article thumbnail

How to Identify Branded Drugs with a Low Likelihood of Generic Entry as Targets for In-Licensing

Drug Patent Watch

Biosimilars and Complex Generics The rise of biosimilars and complex generics is changing the dynamics of market exclusivity. Staying informed about future trends, such as biosimilars and personalized medicine, is crucial for adapting strategies.